Search

Filters

Clear All
  • 14
  • 49
  • 621

Phase

  • 10
  • 16
  • 56
  • 9
  • 74
  • 3
  • 502
  • 597
  • 282
  • 671
  • 13
  • 1
  • 683

Found 684 results for in-health

A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

A Phase 1B/2A Double Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of Cnp-103 in Subjects Ages 12-35 With Recent Onset Stage 3 Type 1 Diabetes

L
Linda DiMeglio, MD
12 years - 35 years
All genders
Phase 1/2
Interventional
This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-103. THIS STUDY IS ENROLLING BY INVITATION ONLY

Trial of VQ Scanning to Reduce Contrast-Induced Nephropathy in Patients Evaluated for Pulmonary Embolism

A
Alice Mitchell
18 years - 100 years
All genders
The purpose of this study is to identify major causes of Acute Kidney Injury (AKI) in the emergency care and hospital settings, to effectively risk-stratify patients, and, ultimately, to prevent or minimize the extent of AKI and subsequent severe health outcomes. The overarching, long-term goal of this research study is …

Risk stratified treatment for patients with newly diagnosed juvenile myelomonocytic leukemia: A Phase I/II non-randomized study of trametinib and azacitidine with or without chemotherapy

S
Sandeep Batra, MD
1 month - 21 years
All genders
Phase 1/2
This clinical trial will test the safety and efficacy of combining trametinib and azacitidine in patients with juvenile myelomonocytic leukemia (JMML). Newly diagnosed lower-risk JMML patients will receive trametinib and azacitidine. High-risk JMML patients will receive trametinib, azacitidine, fludarabine, and cytarabine. THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with …

NF119: A Phase 2, Open-Label, Single Arm, Non-Controlled, Single-Stage Study to Evaluate the Safety and Effects of HLX-1502 in Patients with Plexiform Neurofibroma and Neurofibromatosis Type 1

S
Steven Rhodes
All genders
Phase 2
What is the purpose of this study?The trial will be an open label, single arm, phase 2 study in 20 participants. The study will assess the tolerability and efficacy of HLX-1502 in participants with NF1 16 years of age or older with progressive and/or symptomatic PN. THIS STUDY IS ENROLLING BY …

An Interventional Efficacy and Safety Phase 3 Double-blind 2-arm Study to Investigate IV Followed by Oral Fosmanogepix Compared With IV Caspofungin Followed by Oral Fluconazole in Adult Participants With Candidemia and/or Invasive Candidiasis

N
Nicolas Barros, MD
18 years - 100 years
All genders
Phase 3
Interventional
The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called Fosmanogepix) for the potential treatment of candidemia and/or invasive candidiasis, a life-threatening fungal infection caused by several species of yeast called Candida.The study is seeking patients who have a diagnosis of …

Virtual Reality Cognitive Intervention for Critically Ill Delirium Survivors (Vr-Cog)

S
Sikandar Khan, MD
50 years - 100 years
All genders
Interventional
Acute respiratory failure (ARF) accounts for 2 million admissions to adult intensive care units (ICUs) in the United States annually, and up to 80% of older adults with ARF suffer delirium, a form of ICU-related acute brain dysfunction. Delirium doubles the risk for new cognitive impairment or dementia within 12 …

Collection of Nasal Nitric Oxide in Persons with Suspected Cases of Primary Ciliary Dyskinesia

E
Evans Machogu, MD
All genders
Primary ciliary dyskinesia (PCD) is a genetic condition in which the cilia lining the airway, ears, and sinuses function abnormally. When functionality is abnormal, a buildup of bacteria and debris can accumulate in the lungs, airway, and sinuses, leading to an increased chance of developing infection and bronchiectasis. PCD is …

Enroll-HD: Registry trial for participants with Huntington’s disease

C
Christopher James
Accepts healthy volunteer
All genders
Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America. More than 30,000 participants have now enrolled into the study. With annual assessments and no end date, Enroll-HD …

Congenital Heart Surgeons' Society (CHSS) Studies in Congenital Heart Disease

M
Mark Turrentine, MD
All genders
What is the purpose of this study?The purpose of this study is to participate in a registry of patients with congenital heart disease. Patient data from the United States, Canada, and South America (whose institutions of care are members of the Congenital Heart Surgeon’s Society) will be submitted to this …

Concentration, H2O intake, Urine, Dehydration

A
Andrew Schwaderer, MD
12 years - 18 years
Accepts healthy volunteer
All genders
What is the purpose of this study?The purpose of this study is to determine if urine color can be used to determine urine concentration and hydration status. We will test methodology that can be easily performed by families to monitor hydration status which is an important health consideration. Our primary …
371 - 380 of 684